Osiris Therapeutics completes patient enrollment in first worldwide Phase III stem cell trial.: An article from: Transplant News
Book Details
Author(s)
Gale Reference Team
Publisher
Transplant Communications, Inc.
ISBN / ASIN
B001VMKD26
ISBN-13
978B001VMKD25
Availability
Available for download now
Sales Rank
#99,999,999
Marketplace
United States 🇺🇸
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from Transplant News, published by Transplant Communications, Inc. on December 1, 2008. The length of the article is 379 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details
Title: Osiris Therapeutics completes patient enrollment in first worldwide Phase III stem cell trial.
Author: Gale Reference Team
Publication:Transplant News (Newsletter)
Date: December 1, 2008
Publisher: Transplant Communications, Inc.
Volume: 18 Issue: 12
Distributed by Gale, a part of Cengage Learning
Citation Details
Title: Osiris Therapeutics completes patient enrollment in first worldwide Phase III stem cell trial.
Author: Gale Reference Team
Publication:Transplant News (Newsletter)
Date: December 1, 2008
Publisher: Transplant Communications, Inc.
Volume: 18 Issue: 12
Distributed by Gale, a part of Cengage Learning
